Insmed
INSM
#542
Rank
โ‚น3.908 T
Marketcap
โ‚น18,327
Share price
-0.51%
Change (1 day)
187.29%
Change (1 year)

Insmed (INSM) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น150.92 Billion

According to Insmed's latest financial reports the company has โ‚น150.92 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Insmed - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น123.00 B89.32%
2023-12-31โ‚น64.97 B-31.62%
2022-12-31โ‚น95.02 B78.1%
2021-12-31โ‚น53.35 B36.93%
2020-12-31โ‚น38.96 B12.09%
2019-12-31โ‚น34.75 B0.41%
2018-12-31โ‚น34.61 B42.23%
2017-12-31โ‚น24.33 B120.27%
2016-12-31โ‚น11.04 B-41.22%
2015-12-31โ‚น18.79 B86.28%
2014-12-31โ‚น10.09 B43.42%
2013-12-31โ‚น7.03 B38.28%
2012-12-31โ‚น5.08 B26.11%
2011-12-31โ‚น4.03 B-16.67%
2010-12-31โ‚น4.84 B-14.6%
2009-12-31โ‚น5.66 B4820.68%
2008-12-31โ‚น0.11 B-82.19%
2007-12-31โ‚น0.64 B-39.44%
2006-12-31โ‚น1.06 B26%
2005-12-31โ‚น0.84 B112.22%
2004-12-31โ‚น0.39 B-70.29%
2003-12-31โ‚น1.34 B2.55%
2002-12-31โ‚น1.31 B-46.99%
2001-12-31โ‚น2.47 B-36.23%
2000-12-31โ‚น3.87 B1824.41%
1999-12-31โ‚น0.20 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น76.45 B-49.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น876.17 B 480.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚น660.20 B 337.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น19.90 B-86.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น15.49 B-89.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น564.80 B 274.23%๐Ÿ‡บ๐Ÿ‡ธ USA